News
News Center
Ministry of Science and Technology: Four severe COVID-19 patients have been discharged after receiving stem cell therapy.
2020-02-25
On February 21, the Joint Prevention and Control Mechanism of the State Council for the COVID-19 Epidemic held a press conference. At the briefing, Vice Minister of Science and Technology Xu Nanping announced that four critically ill COVID-19 patients have now been discharged from the hospital after receiving stem-cell therapy, and clinical trials will soon be expanded to further evaluate its effectiveness.
As clinical practice continues to advance, stem cell technology is already proving its effectiveness on the front lines of the fight against the pandemic, offering promising hope for more critically ill patients.
On the afternoon of February 15, the Joint Prevention and Control Mechanism of the State Council held a press conference on the COVID-19 epidemic, providing updates on the latest progress in drug development and scientific research efforts. During the briefing, Zhang Xinmin, Director of the Biotechnology Center at the Ministry of Science and Technology, announced that stem cell therapy has shown promising initial results in treating severe COVID-19 patients, demonstrating both safety and efficacy.
On the afternoon of February 4, Sun Yanrong, Deputy Director of the Biotechnology Center under the Ministry of Science and Technology, stated at a press conference held by the National Health Commission: "In the emergency projects launched by the Ministry of Science and Technology, we have stepped up efforts to accelerate drug development. The scientists working on these urgent initiatives are diligently advancing clinical research into the therapeutic potential of convalescent plasma and stem cells for treating severe cases—always guided by scientific principles, robust informed consent processes, and strict ethical standards. We are eagerly anticipating their groundbreaking progress and sincerely hope that their research will soon yield significant, interim results, ultimately offering renewed hope to our critically ill patients."
On February 3, CCTV conducted an exclusive interview with Academician Li Lanjuan, a member of the National Health Commission's high-level expert team. During the interview, Academician Li repeatedly emphasized the potential of stem cell therapy in treating novel coronavirus pneumonia. She noted that the treatment has proven highly effective after being applied in Zhejiang Province, and even influenza patients have already benefited from stem cell therapy. This time, stem cells will also be used in combination to help rescue critically ill COVID-19 patients.
We believe that, with the joint efforts of our expert team, stem cell technology will further unlock its medical potential and contribute even more to the fight against the COVID-19 pandemic.
Related News
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy